Skip to main content
Unchecking box will stop auto data updates
TSX Venture Real-Time Last Sale CAD
Today's Change
Price Quote as of

Today's Trading

Day Low 2.240
Day High 2.310
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Aleafia Health Inc operates medicinal cannabis clinic network in Canada and has approximately 50,000 patients to date. The company is a federally licensed producer and will reach a funded annual production capacity of approximately 98,000 kilogram of cannabis flower in 2019.


Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio


Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Newly Expanding Sectors Cause an Updraft to the Overall Cannabis Market
- CNW Group - Tue Mar 19, 8:00AM CDT
CNW Group - CMTX
Tue Mar 19, 8:00AM CDT
The cannabis plant is undergoing rapid proliferation around the world. While the plant is still considered illegal in most countries, a handful are beginning to move towards legalizing it. Most of these countries are legalizing cannabis for medical use, but some are possibly looking to legalize it for recreational use as well. Due to the limited research and clinical trials, many countries are still in the process of evaluating cannabis, however, the market is still projected to grow substantially in the shortcoming years. So far, clinical trials have linked cannabis to treating medical conditions such as chronic pain, cancer, Alzheimer's, AIDS, and epilepsy. Recreationally, cannabis is becoming a new source of economic growth, primarily within the U.S. and Canada. Moreover, the North American region is expected to continue to dominate the global cannabis marketplace, as it accounted for 95% of the global market. Specifically, the U.S. alone made up more than 90% of the North American segment despite not having fully legalized cannabis yet. Now, more U.S. states are expected to legalize cannabis in the coming months and years, joining multi-billion dollar states like California and Colorado in the market. According to data compiled by Mordor Intelligence, the global cannabis was valued at USD 7.7 Billion in 2016 and is expected to reach USD 65 Billion by 2023. And additionally, the market is expected to register a robust CAGR of 37% during the period. Biome Grow Inc. (OTC: BIOIF) (CSE: BIO), TILT Holdings Inc. (OTC: SVVTF) (CSE: TILT), Aleafia Health Inc. (OTC: ALEAF) (TSX-V: ALEF), Leafbuyer Technologies, Inc. (OTC: LBUY), Auxly Cannabis Group, Inc. (OTC: CBWTF) (TSX-V: XLY)
Cannabis Reaches New Demographics Due to its Medical Appeal
- CNW Group - Thu Mar 14, 8:00AM CDT
CNW Group - CMTX
Thu Mar 14, 8:00AM CDT
A recent poll by the National Survey on Drug Use and Health has revealed that older generations were increasingly found to be using cannabis. The survey, which was conducted in 2015 and 2016, revealed that 9% of U.S. adults between ages 50 and 64 used a cannabis-based product. And about 3% of people over the age of 65 used cannabis in the same period. The statistics show that cannabis consumption has increased among the older generations since the previous survey in 2013 as almost a quarter of those over 65 were prescribed cannabis as a treatment from their doctors in 2016. Some tried cannabis for recreational use, however, most turn to cannabis for medical reasons. While recreational cannabis laws are still regulated in most U.S. states and even internationally, medical cannabis regulations are much more lenient because of the plant's therapeutic effects. Now, consumers are using cannabis to treat medical conditions such as cancer, chronic pain, and arthritis. According to data compiled by Credence Research, the global medical marijuana market was valued at USD 13.90 Billion in 2017 and is set to reach USD 57.58 Billion. Additionally, the market is expected to witness a CAGR of 17.1% throughout the forecast period from 2018 to 2026. Pressure BioSciences, Inc. (OTC: PBIO), Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON), Acreage Holdings Inc. (OTC: ACRGF) (CSE: ACRG.U), Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT), MariMed Inc. (OTC: MRMD)
New Products Shake up the Burgeoning Cannabis Industry
PR Newswire - Mon Mar 4, 8:00AM CST
PR Newswire - CMTX
Mon Mar 4, 8:00AM CST
The development of the cannabis industry has led to the introduction of a variety of products into the marketplace in recent years. Products such as strains, oils, creams, and tinctures have become popular among consumers. Predominantly, consumers are using these products for medical applications to treat conditions like cancer, migraine, and arthritis. Now, as the industry continues to mature, new products are emerging, chief among them edibles and beverages. While these products may be more popular in the recreational sector, some consumers are leveraging them for their therapeutic effects as well. Such as it is, the current emergence of wide-ranging products is diversifying and helping grow the overall cannabis industry. According to data compiled by Imarc Group, the North American legal cannabis market was valued at approximately USD 8 Billion in 2017. By 2023, the market is expected to reach USD 35 Billion, while exhibiting a CAGR of 28% throughout the forecast period. Weekend Unlimited Inc. (OTC: WKULF) (CSE: POT), Emerald Health Therapeutics, Inc. (OTC: EMHTF) (TSX-V: EMH), General Cannabis Corp. (OTC: CANN), Aleafia Health Inc. (OTC: ALEAF) (TSX-V: ALEF), Leafbuyer Technologies, Inc. (OTC: LBUY)
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 2.160 +4.63% increase
on 03/13/19
Period Open:2.360
Price movement based on the high, low and last over the given period.
2.670 -15.36% decrease
on 02/26/19
-0.100 (-4.24%) decrease
since 02/15/19
3-Month 1.190 +89.92% increase
on 12/24/18
Period Open:1.440
Price movement based on the high, low and last over the given period.
2.930 -22.87% decrease
on 02/05/19
+0.820 (+56.94%) increase
since 12/18/18
52-Week 0.470 +380.85% increase
on 04/10/18
Period Open:0.690
Price movement based on the high, low and last over the given period.
4.700 -51.91% decrease
on 09/26/18
+1.570 (+227.54%) increase
since 12/22/17

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).